HealthStream Inc

HealthStream Inc (HSTM) Stock Analysis

$29.670

+0.632 (+2.13%)At close

Loading chart…
High
29.700
Open
28.940
VWAP
29.40
Vol
226.51K
Mkt Cap
846.58M
Low
28.840
Amount
6.66M
EV/EBITDA, TTM
10.37

HealthStream, Inc. provides platform-delivered workforce solutions. Its solutions include Software-as-a-Service (SaaS), subscription-based applications used by healthcare organizations to meet a range of their workforce development needs around learning, clinical development, credentialing, and scheduling. Its content libraries allow customers to subscribe to an array of courseware, which includes content from healthcare and nursing associations, medical and healthcare publishers, and other content providers. Its scheduling solutions provide customers with real-time visibility into clinical staff scheduling. Its credentialing, privileging, and enrollment solution, CredentialStream, provides customers a user experience with a continual stream of enhancements, evidence-based content, and curated data, which provides healthcare organizations with tools to support the provider lifecycle management from recruiting, application submission, verification of licensure, and other credentials.

AI analysis of HealthStream Inc (HSTM)

hold

HealthStream Inc is currently trading at $29.38, which is above the analyst price target of $27, indicating that it may be overvalued at this time. The stock has an RSI of 69.19, suggesting it is nearing overbought territory. Although the company reported a solid Q2 with a 12.5% revenue increase to $83.73 million and earnings per share of $0.23, the forward P/E ratio of 45.66 is significantly high, indicating potential overvaluation. Furthermore, insider selling has increased by 146.37%, which raises concerns about the stock's future performance. Therefore, while the company shows growth potential, it may be prudent to hold rather than buy at the current price.

Analyst Ratings (9)

-15.74% downside
Hold
4 Buy
5 Hold
0 Sell
Current: 29.67
Low
25.00
Average
25.00
High
25.00

Canaccord

2026-07-21

Price Target

$27

Hold

Canaccord

2026-05-06

Price Target

$24

Hold

Canaccord

2026-02-25

Price Target

$21

Hold

Canaccord

2026-01-08

Price Target

$25

Hold

Canaccord

2025-08-07

Price Target

$28

Hold

Valuation Metrics

The current forward P/E ratio for HealthStream Inc (HSTM) is 45.66, compared to its 5-year average forward P/E of 58.85.

Forward P/E

Fair
5Y Average P/E
58.85
Current P/E
45.66
Overvalued
90.30
Undervalued
27.39

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
11.77
Current EV/EBITDA
10.37
Overvalued
13.78
Undervalued
9.76

Forward P/S

Fair
5Y Average P/S
2.64
Current P/S
2.47
Overvalued
3.04
Undervalued
2.24

Alphio AI Price Scenarios for HSTM

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%HSTM

$27.38

Scenario price

B

Base

Base · 50%HSTM

$25.98

Scenario price

B

Bear

Bear · 25%HSTM

$21.36

Scenario price

Whales holding HSTM

P

Punch & Associates Investment Management, Inc.

+ HoldingHSTM

+0.23%

3M Return

Events Timeline

2026-08-11 (ET)

08:30:00

Humana Collaborates with HealthStream to Expand Healthcare Services in Indiana

2026-08-03 (ET)

17:00:00

Now Projects 2026 Adjusted EBITDA of $74M-$78M

17:00:00

Company Reports Q2 Revenue of $83.7M

2026-05-04 (ET)

16:40:00

Company Confirms FY26 Adjusted EBITDA Outlook of $73M-$77M

16:40:00

Company Reports Q2 Revenue of $81.2M

News

HSTM FAQ — answered by Alphio AI

HealthStream, Inc. provides platform-delivered workforce solutions. Its solutions include Software-as-a-Service (SaaS), subscription-based applications used by healthcare organizations to meet a range of their workforce development needs around learning, clinical development, credentialing, and scheduling. Its content libraries allow customers to subscribe to an array of courseware, which includes content from healthcare and nursing associations, medical and healthcare publishers, and other content providers. Its scheduling solutions provide customers with real-time visibility into clinical staff scheduling. Its credentialing, privileging, and enrollment solution, CredentialStream, provides customers a user experience with a continual stream of enhancements, evidence-based content, and curated data, which provides healthcare organizations with tools to support the provider lifecycle management from recruiting, application submission, verification of licensure, and other credentials. It operates in the Technology sector (SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ET industry).

HealthStream Inc is currently trading at $29.38, which is above the analyst price target of $27, indicating that it may be overvalued at this time. The stock has an RSI of 69.19, suggesting it is nearing overbought territory. Although the company reported a solid Q2 with a 12.5% revenue increase to $83.73 million and earnings per share of $0.23, the forward P/E ratio of 45.66 is significantly high, indicating potential overvaluation. Furthermore, insider selling has increased by 146.37%, which raises concerns about the stock's future performance. Therefore, while the company shows growth potential, it may be prudent to hold rather than buy at the current price.

9 analysts cover HSTM: 4 rate it Buy, 5 Hold and 0 Sell. The average price target is 25.00.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started